BRPI1016026A2 - composição, métodos para regular uma atividade nervosa autônoma, para promover a atividade nervosa parassimpática, para suprimir um aumento em uma atividade nervosa simpática em um animal não humano, para promover a motilidade gastrointestinal, para prevenir a amnésia, e, para reduzir a ansiedade, e, agente. - Google Patents
composição, métodos para regular uma atividade nervosa autônoma, para promover a atividade nervosa parassimpática, para suprimir um aumento em uma atividade nervosa simpática em um animal não humano, para promover a motilidade gastrointestinal, para prevenir a amnésia, e, para reduzir a ansiedade, e, agente.Info
- Publication number
- BRPI1016026A2 BRPI1016026A2 BRPI1016026A BRPI1016026A BRPI1016026A2 BR PI1016026 A2 BRPI1016026 A2 BR PI1016026A2 BR PI1016026 A BRPI1016026 A BR PI1016026A BR PI1016026 A BRPI1016026 A BR PI1016026A BR PI1016026 A2 BRPI1016026 A2 BR PI1016026A2
- Authority
- BR
- Brazil
- Prior art keywords
- nerve activity
- promoting
- suppressing
- composition
- methods
- Prior art date
Links
- 230000008035 nerve activity Effects 0.000 title 3
- 230000001737 promoting effect Effects 0.000 title 2
- 208000000044 Amnesia Diseases 0.000 title 1
- 208000031091 Amnestic disease Diseases 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 230000006986 amnesia Effects 0.000 title 1
- 230000036506 anxiety Effects 0.000 title 1
- 210000000467 autonomic pathway Anatomy 0.000 title 1
- 230000005176 gastrointestinal motility Effects 0.000 title 1
- 210000005037 parasympathetic nerve Anatomy 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 230000002889 sympathetic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009078015 | 2009-03-27 | ||
| PCT/JP2010/055413 WO2010110439A1 (ja) | 2009-03-27 | 2010-03-26 | 自律神経活動調節用組成物および自律神経を調節する方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1016026A2 true BRPI1016026A2 (pt) | 2016-05-10 |
Family
ID=42781129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1016026A BRPI1016026A2 (pt) | 2009-03-27 | 2010-03-26 | composição, métodos para regular uma atividade nervosa autônoma, para promover a atividade nervosa parassimpática, para suprimir um aumento em uma atividade nervosa simpática em um animal não humano, para promover a motilidade gastrointestinal, para prevenir a amnésia, e, para reduzir a ansiedade, e, agente. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120015882A1 (ja) |
| EP (1) | EP2412379A4 (ja) |
| JP (1) | JP5677937B2 (ja) |
| KR (1) | KR20110136879A (ja) |
| CN (1) | CN102448480A (ja) |
| BR (1) | BRPI1016026A2 (ja) |
| CA (1) | CA2756107A1 (ja) |
| MX (1) | MX2011010077A (ja) |
| SG (1) | SG174456A1 (ja) |
| TW (1) | TW201039839A (ja) |
| WO (1) | WO2010110439A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6098929B2 (ja) * | 2013-02-22 | 2017-03-22 | 国立大学法人京都大学 | 抗うつ剤又は抗不安剤 |
| CN107517585A (zh) * | 2015-05-13 | 2017-12-26 | 朝日可尔必思健康株式会社 | 抑制运动时的心率上升的方法和抑制心率上升的组合物 |
| CN113896761A (zh) * | 2021-09-15 | 2022-01-07 | 湖北泓肽生物科技有限公司 | 一种l-酪氨酰-l-脯氨酸的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3047596A1 (de) * | 1980-12-17 | 1982-07-22 | Victor Dipl.- Chem. 8000 München Brantl | Pharmakologisch aktive dipeptide |
| US4931430A (en) * | 1987-12-14 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method for preventing or treating anxiety employing an ACE inhibitor |
| IL88502A (en) * | 1987-12-14 | 1993-04-04 | Squibb & Sons Inc | Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor |
| JP3193763B2 (ja) | 1992-03-03 | 2001-07-30 | 日清製粉株式会社 | ペプチド |
| SE9600120D0 (sv) * | 1996-01-15 | 1996-01-15 | Astra Ab | Novel medical use |
| US5854029A (en) * | 1996-08-02 | 1998-12-29 | Calpis Co., Ltd. | Method for preparing antihypertensive agent |
| CA2411261A1 (en) * | 2000-06-01 | 2001-12-06 | Robert C. Kevorkian | Use of ace inhibitors for treatment of patients suffering from behavioral disorders |
| ATE328596T1 (de) | 2001-03-16 | 2006-06-15 | Suntory Ltd | Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel |
| EP1879465A1 (en) * | 2005-02-09 | 2008-01-23 | Unilever N.V. | Composition comprising peptide |
| RU2005128993A (ru) | 2005-09-08 | 2007-03-20 | Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) | Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний |
-
2010
- 2010-03-26 WO PCT/JP2010/055413 patent/WO2010110439A1/ja not_active Ceased
- 2010-03-26 TW TW099109033A patent/TW201039839A/zh unknown
- 2010-03-26 SG SG2011067352A patent/SG174456A1/en unknown
- 2010-03-26 BR BRPI1016026A patent/BRPI1016026A2/pt not_active IP Right Cessation
- 2010-03-26 JP JP2011506152A patent/JP5677937B2/ja active Active
- 2010-03-26 CA CA2756107A patent/CA2756107A1/en not_active Abandoned
- 2010-03-26 EP EP10756235A patent/EP2412379A4/en not_active Withdrawn
- 2010-03-26 CN CN2010800233035A patent/CN102448480A/zh active Pending
- 2010-03-26 KR KR1020117025374A patent/KR20110136879A/ko not_active Withdrawn
- 2010-03-26 MX MX2011010077A patent/MX2011010077A/es active IP Right Grant
-
2011
- 2011-09-26 US US13/245,449 patent/US20120015882A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW201039839A (en) | 2010-11-16 |
| US20120015882A1 (en) | 2012-01-19 |
| CN102448480A (zh) | 2012-05-09 |
| EP2412379A1 (en) | 2012-02-01 |
| CA2756107A1 (en) | 2010-09-30 |
| WO2010110439A1 (ja) | 2010-09-30 |
| KR20110136879A (ko) | 2011-12-21 |
| SG174456A1 (en) | 2011-10-28 |
| JP5677937B2 (ja) | 2015-02-25 |
| JPWO2010110439A1 (ja) | 2012-10-04 |
| MX2011010077A (es) | 2011-10-11 |
| EP2412379A4 (en) | 2012-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2918222A4 (en) | LIVING, MENTAL AND PERSONAL HEALTH INFORMATION PLATFORM | |
| GB2536582B (en) | Diesel oxidation catalyst with NOx adsorber activity | |
| BR112015006996A2 (pt) | método para reduzir a quantidade de enxofre em uma composição que compreende enxofre, e, composição. | |
| LTPA2017007I1 (lt) | Terapiniai agentai, skirti prieskydinės liaukos hormono lygio sumažinimui | |
| GB2475740B (en) | Catalysts for treating transient NOx emissions | |
| DK3382016T3 (da) | Polypeptider med xylanaseaktivitet og polynukleotider, der koder for dem | |
| LT2847304T (lt) | Inžinerijos būdu sukurtų kuro žaliavų su sumažintu chloro kiekiu gamybos būdas | |
| BR112013017851A2 (pt) | método para reduzir níveis de colágeno de c-telopeptídeo do tipo ii | |
| BRPI1007561A2 (pt) | método para revitalizar uma composição contendo betume, e, composição | |
| GB201411274D0 (en) | Improvements in and relating to neurostimulating devices for treating pain, improving function and other nervous system related conditions. | |
| SG11201502713QA (en) | Compositions, structures and methods for neural regeneration | |
| ZA201104464B (en) | Coal rope distributor with replaceable wear components | |
| FI20125294L (fi) | Menetelmä pyrolyysiöljyn jalostamiseksi, käsitelty pyrolyysiöljy ja sen käyttö | |
| EP2971259A4 (en) | SYNERGISTIC ADDITIVES FOR ELECTROCHEMICAL CELLS HAVING GALVANICALLY FELT FUEL | |
| BRPI0913362A2 (pt) | método para produzir carvão pulverizado. | |
| DK2756078T3 (da) | Sammensætninger, der omfatter enzymer med endo-1, 4-beta- xylanaseaktivitet og enzymer med endo-1,3(4)-betaglucanaseaktivitet | |
| BR112015002739A2 (pt) | métodos para intensificar, melhorar ou sustentar saúde e/ou função cognitiva em mamíferos, e para tratar ou prevenir um declínio em saúde e/ou função cognitiva em mamíferos | |
| DK2751354T3 (da) | Ovenlysvindue med forbedret anslagslistekapsel | |
| EP2770449A4 (en) | MULTI-TYPE DESIGN DEVICE, MULTIKART DESIGN PROCESS, PROGRAM AND COMPUTER READABLE RECORDING MEDIUM | |
| BR112012006437A2 (pt) | composições e métodos para tratamento do diabetes e outros distúrbios | |
| EP2768931A4 (en) | PROCESS FOR REDUCING THE DEVELOPMENT OF HYDROGEN SULFIDE FROM ASPHALT AND SULFIDE DEVELOPMENT OF HEAVY FUEL OILS FROM ASPHALT AND HEAVY FUEL OILS | |
| EP2844486A4 (en) | ARRANGEMENT AND METHOD FOR SERVICING AN INKJET PRINTER | |
| BR112014028635A2 (pt) | projétil e cartucho isentos de chumbo , e , método para reduzir o desgaste entre um projétil e uma arma | |
| BR112012021236A2 (pt) | método para produzir composição de isocianato modificada por uretonimina, e, composição de isocianato modificada por uretonimina | |
| EP2619722A4 (en) | CONTROLLING THE EXPANSION OF A WEBSITE BEHAVIOR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |